SIRT1 and Alzheimer disease: The findings in this study reveal that Resveratrol; which activates SIRT1; which in turn deacetylates TFEB, could regulate lysosomal biogenesis and fAβ degradation making microglial activation of TFEB a possible strategy for attenuating amyloid plaque deposition in AD.